MAP-2 expression in the human adenohypophysis and in pituitary adenomas. An immunohistochemical study

Pituitary

Volumn 8, Issue 2, 2005, Pages 75-79

  Rotondo, Fabio ^a   Oniya, Kenichi ^a   Kovacs, Kalman ^a   Bell, C David ^a   Scheithauer, Bernd W ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

Adenohypophysis; Immunohistochemistry; Microtubule Associated proteins; Pituitary adenomas

Indexed keywords

BIOTIN; CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; MICROTUBULE ASSOCIATED PROTEIN 2; PEROXIDASE; PROLACTIN; STREPTAVIDIN; THYROTROPIN;

ADENOHYPOPHYSIS; ADULT; AGE; AGED; ALPHA CHAIN; ARTICLE; AUTOPSY; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE ASSOCIATION; ENDOCRINE FUNCTION; FEMALE; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROTUBULE ASSEMBLY; MITOSIS RATE; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEX DIFFERENCE; SEX RATIO; TUMOR GROWTH;

ADENOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS;

EID: 33644512818     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-005-1523-4     Document Type: Article

References (38)

1. Wiche G, Oberkanins C, Himmler A. Molecular structure and function of microtubule-associated proteins. Int Rev Cytol 1991;124:217-273.
2. Maccioni RB, Cambiazo V. Role of microtubule-associated proteins in the control of microtubule assembly. Physiol Rev 1995;75:835-864.
3. Matsunaga W, Miyata S, Hashimoto Y, Lin SH, Nakashima T, Kiyohara T, Matsumoto T. Microtubule-associated protein-2 in the hypothalamo-neurohypophysial system: Low-molecular-weight microtubule-associated protein-2 in pituitary astrocytes. Neuroscience 1999;88:1289-1297.
4. Matsunaga W, Osawa S, Miyata S, Kiyohara T. Astrocytic Fos expression in the rat posterior pituitary following LPS administration. Brain Res 2001;898:215-223.
5. Matsunaga W, Miyata S, Itoh M, Kiyohara T, Maekawa S. Expression of high levels of tubulin and microtubule-associated protein 2d in the neurohypophysial astrocytes of adult rat. Neuroscience 2002;111:151-162.
6. Bloom GS, Luca FC, Vallee RB. Identification of high molecular weight microtubule-associated proteins in anterior pituitary tissue and cells using Taxol-dependent purification combined with microtubule-associated protein specific antibodies. Biochemistry 1985;24:4185-4191.
7. Tooze J, Hollinshead M, Fuller SD, Tooze SA, Huttner WB. Morphological and biochemical evidence showing neuronal properties in AtT-20 cells and their growth cones. Eur J Cell Biol 1989;49:259-273.
8. Martinez de la Escalera G, Weiner RI. Hypothalamic regulation of microtubule-associated protein phosphorylation in lactotrophs. Neuroendocrinology 1992;55:327-335.
9. Matsuno A, Takekoshi S, Sanno N, Utsunomiya H, Ohsugi Y, Saito N, Kanemitsu H, Tamura A, Nagashima T, Osamura RY, Watanabe K. Modulation of protein kinases and microtubule-associated proteins and changes in ultrastructure in female rat pituitary cells: Effects of estrogen and bromocriptine. J Histochem Cytochem 1997;45:805-813.
10. Frierson HF Jr, Ross GW, Mills SE, Frankfurter A. Olfactory neuroblastoma: Additional immunohistochemical characterization. Am J Clin Pathol 1990;94:547-553.
11. Veitia R, David S, Barbier P, Vantard M, Gounon P, Bissery MC, Fellous A. Proteolysis of microtubule associated protein 2 and sensitivity of pancreatic tumours to docetaxel. Br J Cancer 2000;83:544-549.
12. Blumcke I, Becker AJ, Normann S, Hans V, Riederer BM, Krajewski S, Wiestler OD, Reifenberger G. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells. J Neuropathol Exp Neurol 2001;60:984-993.
13. Eberhart CG, Kaufman WE, Tihan T, Burger PC. Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules. J Neuropathol Exp Neurol 2001;60:462-469.
14. Fang D, Hallman J, Sangha N, Kute TE, Hammarback JA, White WL, Setaluri V. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: Implications for differentiation and progression of cutaneaous melanoma. Am J Pathol 2001;158:2107-2115.
15. Liu Y, Sturgis CD, Grzybicki DM, Jasnosz KM, Olson PR, Tong M, Dabbs DD, Raab SS, Silverman JF. Microtubule-associated protein-2: A new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma. Mod Pathol 2001;14:880-885.
16. Suzuki SO, Kitai R, Llena J, Lee SC, Goldman JE, Shafit-Zagardo B. MAP-2e, a novel MAP-2 isoform, is expressed in gliomas and delineates tumor architecture and patterns of infiltration. J Neuropathol Exp Neurol 2002;61:403-412.
17. Liu Y, Mangini J, Saad R, Silverman AR, Abell E, Tung MY, Graner SR, Silverman JF. Diagnostic value of microtubule-associated protein-2 in Merkel cell carcinoma. Appl Immunohistochem Mol Morphol 2003;11:326-329.
18. Blumcke I, Müller S, Buslei R, Riederer BM, Wiestler OD. Microtubule-associated protein-2 immunoreactivity: A useful tool in the differential diagnosis of low-grade neuroepithelial tumors. Acta Neuropathol 2004;108:89-96.
19. Kovacs K, Lloyd R, Horvath E, Asa SL, Stefaneanu L, Killinger DW, Smyth HS. Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in-situ hybridization. Am J Pathol 1989;134:345-353.
20. Rotondo F, Vidal S, Bell D, Horvath E, Kovacs K, Scheithauer BW, Lloyd RV. Immunohistochemical localization of amylin in human pancreas, thyroid, pituitary and their tumors. Acta Histochem 2003;105:303-307.
21. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ER Jr. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody. Neurosurgery 1996;38:99-106.
22. Thapar K, Yamada Y, Scheithauer B, Kovacs K, Yamada S, Stefaneanu L. Assessment of Mitotic Activity in Pituitary Adenomas and Carcinomas. Endocr Pathol 1996;7:215-221.
23. Matsunaga W, Miyata S, Kiyohara T. Redistribution of MAP2 immunoreactivity in the neurohypophysial astrocytes of adult rats during dehydration. Brain Res 1999;829:7-17.
24. Jefferson AB, Schulman H. Phosphorylation of microtubule-associated protein-2 in GH3 cells: Regulation by cAMP and by calcium. J Biol Chem 1991;266:346-354.
25. D'Andrea MR, Ilyin S, Plata-Salaman CR. Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantia nigra brain tissues. Neurosci Lett. 2001;306:137-140.
26. Burns LH, Jin Z, Bowersox SS. The neuroprotective effects of intrathecal administration of the selective N-type calcium channel blocker ziconotide in a rat model of spinal ischemia. J Vasc Surg 1999;30:334-343.
27. Ikeda T, Xia XY, Xia YX, Ikenoue T. Hyperthermic preconditioning prevents blood-brain barrier disruption produced by hypoxia-ischemia in newborn rat. Brain Res Dev Brain Res 1999;117:53-58.
28. Li GL, Farooque M, Lewen A, Lennmyr F, Holtz A, Olsson Y. MAP2 and neurogranin as markers for dendritic lesions in CNS injury. An immunohistochemical study in the rat. APMIS 2000;108:98-106.
29. Yu WR, Westergren H, Farooque M, Holtz A, Olsson Y. Systemic hypothermia following spinal cord compression injury in the rat: An immunohistochemical study on MAP 2 with special reference to dendrite changes. Acta Neuropathol 2000;100:546-552.
30. Clancy B, Silva-Filho M, Friedlander MJ. Structure and projections of white matter neurons in the postnatal rat visual cortex. J Comp Neurol 2001;434:233-252.
31. Kaufmann WE, MacDonald SM, Altamura CR. Dendritic cytoskeletal protein expression in mental retardation: An immunohistochemical study of the neocortex in Rett syndrome. Cerebral Cortex 2000;10:992-1004.
32. Ohara S, Tsukada M, Ikeda SI. On the occurrence of neuronal sprouting in the frontal cortex of a patient with Down's syndrome. Acta Neuropathol 1999;97:85-90.
33. Lang-Lazdunski L, Heurteaux C, Mignon A, Mantz J, Widmann C, Desmonts J, Lazdunski M. Ischemic spinal cord injury induced by aortic cross-clamping: Prevention by riluzole. Eur J Cardiothorac Surg 2000;18:174-181.
34. Lang-Lazdunski L, Heurteaux C, Dupont H, Widmann C, Lazdunski M. Prevention of ischemic spinal cord injury: Comparative effects of magnesium sulfate and riluzole. J Vasc Surg 2000;32:179-189.
35. Hutter-Paier B, Grygar E, Loibner M, Skofitsch G, Windisch M. Effects of NaCN and ionomycin on neuronal viability and on the abundance of microtubule-associated proteins MAP1, MAP2, and tau in isolated chick cortical neurons. Cell Tissue Res 2000;306:39-47.
36. Lee JH, Hong HN, Im JO, Byun HS, Kim D. The formation of PHF-1 and SMI-31 positive dystrophic neuritis in rat hippocampus following acute injection of okadaic acid. Neurosci Lett 2000;282:49-52.
37. Baulieu EE. 'New' active steroids and an unforeseen mechanism of action. C R Acad Sci III 2000;323:513-518.
38. Schwab M, Antonow-Schlorke I, Kuhn B, Muller T, Schubert H, Walter B, Sliwka U, Nathanielsz PW. Effect of antenatal betamethasone treatment on microtubule-associated proteins MAP1B and MAP2 in fetal sheep. J Physiol 2001;520:497-506.